I couldn't
open that link, but a problem with nomograms is that they lose predictive value for small subgroups, such as those who were given HT when they only had G6 at the margin.
Here are a couple of references that were for adjuvant ADT used with primary therapy (not salvage therapy), but if ADT is useless in one, it's probably useless in the other:
"our study suggests a benefit in patients with Percent Positive Cores greater than 50%, GS 4+3, or multiple risk factors. "
www.redjournal.org/article/S0360-3016(11)03443-2/fulltext"Favorable intermediate-risk patients had no significant benefit from the addition of ADT to RT"
www.redjournal.org/article/S0360-3016(12)00856-5/fulltextAlso, since the positive margin was only GS 6 and there may be a small amount of GS 6 left in there, is this something that you want to treat, or is an active surveillance approach better for you? Here's some useful info about
the risk of GS 6 sometimes it progresses, but in over half the cases, it never does.
/pcnrv.blogspot.com/2017/11/myth-gleason-6-never-progresses.html